Client News

Healthcare Triangle (HCTI) Acquires DevCool, an Electronic Health Record (EHR) Focused Healthcare IT and Managed Services Company

Acquisition Expected to Add Approximately $20 Million in Revenues PLEASANTON, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) — Healthcare Triangle, Inc. (HCTI), a leading provider of Healthcare and Life Sciences cloud transformation, managed services and data analytics platform company, announced today that it has acquired DevCool, Inc. (“DevCool”), ranked by Inc. 5000 as among the fastest […]

Applied UV Continues Global Expansion with Airocide(R) Installations in Thailand at the Acclaimed Armed Forces Research Institute of Medical Sciences (“AFRIMS”)

AFRIMS to install Airocide® technology to protect visitors and staff AFRIMS is a biomedical research facility of the U.S. Army’s Walter Reed Army Institute of Research MOUNT VERNON, NY / ACCESSWIRE / December 1, 2021 / Applied UV, Inc. (NASDAQ:AUVI) (“Applied UV” or the “Company”), a pathogen elimination technology company that applies the power of narrow-range ultraviolet […]

Longeveron Announces Phase 2 Clinical Trial in Japan to Test Safety and Efficacy of Lomecel-B on Aging Frailty Patients

New trial is in collaboration with Japan’s National Center for Geriatrics and Gerontology (NCGG) and Juntendo University Hospital MIAMI, Nov. 30, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and certain life-threatening conditions, announced today that it has entered into […]

Pasithea Therapeutics Adds Esketamine Nasal Spray to its Clinic Offerings in the U.K.

Pasithea Clinics is one of only three accredited clinics in the U.K. approved to offer esketamine nasal spray (SPRAVATO®) for treatment of mental health disorders MIAMI BEACH, Fla., Nov. 23, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel biotechnology company focused on the research and discovery of new […]

U.S. Food and Drug Administration Approves Longeveron’s Lomecel-B for Rare Pediatric Disease Designation to Treat Life-Threatening Infant Heart Condition

Phase 2 clinical trial underway for Hypoplastic Left Heart Syndrome, which affects approximately 1,000 babies per year MIAMI, Nov. 18, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, announced today that the U.S. Food and Drug Administration (FDA) […]

Pressure BioSciences, Inc. Q3 Financial Results Maintain Solid 2021 YTD Growth

Operational and Technical Achievements Set Stage for Expected Major Growth and Profitability in 2022 Investor Call Scheduled for Wednesday, November 17, 2021 at 4:30 p.m. ET SOUTH EASTON, MA / ACCESSWIRE / November 17, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, […]

Applied UV Reports Third Quarter 2021 Results

Results: Revenue increased 88.5% to $3.55 million as compared to $1.88 in the previous quarter Gross profit increased to $1.0 million, or 29.6% vs. sales as compared to $0.5m, or 28.3% vs. sales in the previous quarter Net loss improved 49% to $(1,080,805) as compared to a net loss of $(2,138,231) in the previous quarter […]

Muscle Maker, Inc. Posts Another Triple Digit Revenue Increase in Q3, Improving Financial Results

Health-focused restaurant company experiences 190% revenue gains as the integration of recent acquisitions begins to be reported League City, Texas, Nov. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Muscle Maker, Inc. (Nasdaq: GRIL), the parent company of Muscle Maker Grill, Pokemoto and Superfit Foods, today announced the posting of its third quarter 2021 financial results on November […]

Applied UV Reports Third Quarter 2021 Results

Results: Revenue increased 88.5% to $3.55 million as compared to $1.88 in the previous quarter Gross profit increased to $1.0 million, or 29.6% vs. sales as compared to $0.5m, or 28.3% vs. sales in the previous quarter Net loss improved 49% to $(1,080,805) as compared to a net loss of $(2,138,231) in the previous quarter […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.